DOI: 10.4244/EIJV9I1A24

“First-in-man” use of bioresorbable vascular scaffold in saphenous vein graft

Paul Jau Lueng Ong, MD, FESC; Fahim Haider Jafary, MD, FACC; Hee Hwa Ho*, MD, FACC

A 52-year-old male underwent coronary angiography for non-ST-elevation myocardial infarction. He had a known history of diabetes mellitus and also triple vessel disease with prior coronary artery bypass grafting (CABG) six years ago. Angiography showed total occlusion of the left anterior descending (LAD), circumflex and right coronary arteries (RCA). Left internal mammary graft to LAD was patent. However, there were two critical stenoses in the mid-body of the SVG-RCA and SVG-obtuse marginal (OM) grafts (Figure 1A and Figure 1B). We proceeded to perform percutaneous coronary intervention of both lesions with the prophylactic use of an embolic protection device. After predilation of both lesions, an Absorb™ bioresorbable vascular scaffold 3.0×18 mm (Abbott Vascular, Santa Clara, CA, USA) was implanted in the mid-body of the saphenous vein graft (SVG)-RCA (Figure 1C) whereas a XIENCE PRIME™ 3.0×23 mm stent (Abbott Vascular) was implanted in the mid-body of the SVG-OM (Figure 1D). The final angiographic results were good and there was no in-lab complication. He presented three months later with atypical chest pain and underwent cardiac computed tomographic angiography (CCTA). Both bioresorbable vascular scaffold (BVS) and XIENCE PRIME stent were widely patent on CCTA (Figure 1E and Figure 1F). No blooming artefact was observed within the treated SVG-RCA segment with the BVS platinum markers clearly seen on CCTA.

Figure 1. A) Baseline angiography showing critical stenosis in mid-body of SVG-RCA. B) Baseline angiography showing critical stenosis in mid-body of SVG-OM. C) Final angiography of SVG-RCA (after successful deployment of Absorb). D) Final angiography of SVG-OM (after successful deployment of XIENCE stent). E) CCTA showing widely patent BVS in mid-body of SVG-RCA. No blooming artefact observed with the BVS platinum markers clearly seen (small arrowheads >>) on CCTA. F) CCTA showing widely patent XIENCE metallic stent in mid-body of SVG-OM.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Online data supplement

Moving image 1. Movie clip showing the appearance of BVS in the mid-body of the SVG-RCA on CCTA.

Moving image 2. Movie clip showing the appearance of XIENCE stent in the mid-body of the SVG-OM on CCTA.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1.
Moving image 2.
Volume 9 Number 1
May 21, 2013
Volume 9 Number 1
View full issue


Key metrics

Suggested by Cory

CLINICAL RESEARCH

10.4244/EIJ-D-17-00246 Jul 20, 2017
One-year clinical results of the Italian diffuse/multivessel disease ABSORB prospective registry (IT-DISAPPEARS)
Testa L et al
free
Trending articles
312.73

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
241.95

State of the art

10.4244/EIJ-D-21-01117 Sep 20, 2022
Recanalisation of coronary chronic total occlusions
Di Mario C et al
free
153.78

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
110.9

Clinical research

10.4244/EIJ-D-20-00130 Oct 9, 2020
Double-kissing culotte technique for coronary bifurcation stenting
Toth GG et al
free
105.53

Expert consensus

10.4244/EIJ-E-22-00018 Dec 4, 2023
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M et al
free
77.75

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
43.4

Clinical research

10.4244/EIJ-D-23-00590 Dec 4, 2023
Prognostic impact of cardiac damage staging classification in each aortic stenosis subtype undergoing TAVI
Nakase M et al
free
34.75

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved